Online citations, reference lists, and bibliographies.
← Back to Search

Diffusion-weighted MRI Of Malignant Pleural Mesothelioma: Preliminary Assessment Of Apparent Diffusion Coefficient In Histologic Subtypes.

R. Gill, S. Umeoka, H. Mamata, T. R. Tilleman, P. Stanwell, R. Woodhams, R. Padera, D. Sugarbaker, H. Hatabu
Published 2010 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
OBJECTIVE The purpose of this study was to prospectively assess, in the evaluation of patients with suspected malignant pleural mesothelioma (MPM), apparent diffusion coefficient (ADC) values derived from diffusion-weighted images obtained with a free-breathing single-shot spin-echo echo-planar imaging sequence and to correlate the ADC values with the three histologic subtypes of MPM. SUBJECTS AND METHODS Sixty-two patients with a known pleural abnormality and clinical findings suggestive of MPM underwent diffusion-weighted 3-T MRI and ADC calculation. The pathologic diagnosis was confirmed by surgical procedure. ADC values were correlated with the histologic subtypes of MPM. Statistical analysis was performed with analysis of variance and the Student's t test. RESULTS Fifty-seven patients had MPM. Forty of the tumors were epithelioid, 11 were biphasic, and six were sarcomatoid. The other five patients had pleural thickening (two patients), metastatic adenocarcinoma (one patient), chronic inflammation (one patient), and malignant lymphoma (one patient). Because of image distortion, the diffusion-weighted images and ADC maps were not satisfactory for assessment in seven cases. The ADC values of MPM were 1.31 +/- 0.15 x 10(-3) mm(2)/s for the epithelioid, 1.01 +/- 0.11 x 10(-3) mm(2)/s for the biphasic, and 0.99 +/- 0.07 x 10(-3) mm(2)/s for the sarcomatoid subtypes of MPM. The ADC of the epithelioid subtype was statistically significantly higher than that of the sarcomatoid subtype (p < 0.05). The ADC in the two cases of benign plaque was 0.85 +/- 0.17 x 10(-3) mm(2)/s. CONCLUSION The ADC values of epithelioid mesothelioma are higher than those of sarcomatoid mesothelioma. There is no significant difference between the ACD values of biphasic and those of sarcomatoid MPM.
This paper references
10.1056/NEJMRA050152
Advances in malignant mesothelioma.
B. Robinson (2005)
10.1002/jmri.21569
Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free‐breathing diffusion‐weighted MR imaging of the liver
T. Kwee (2008)
10.1002/mrm.10308
Reduction of eddy‐current‐induced distortion in diffusion MRI using a twice‐refocused spin echo
T. G. Reese (2003)
10.1053/SONC.2002.30227
The pathogenesis of mesothelioma.
M. Carbone (2002)
10.1007/s00330-008-0968-z
Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology
T. Kwee (2008)
10.1016/S0090-3019(02)00929-1
Diffusion-weighted MR imaging in the preoperative assessment of brain abscesses.
E. Leuthardt (2002)
Latent period for malignant mesothelioma of occupational origin.
B. Lanphear (1992)
10.1200/JCO.2008.19.8523
Malignant pleural mesothelioma.
A. Tsao (2009)
10.1093/ANNONC/MDM093
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
W. Weder (2007)
10.1016/j.ejrad.2009.03.054
Whole-body diffusion-weighted magnetic resonance imaging.
T. Kwee (2009)
10.2463/MRMS.6.211
Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body.
D. Koh (2007)
10.1002/mrm.20190
In vivo diffusion tensor imaging of the human prostate
S. Sinha (2004)
10.1016/j.mric.2010.09.006
Diffusion-weighted imaging of the chest.
A. Luna (2011)
10.1016/j.cpet.2011.04.001
Multimodality Imaging Review of Malignant Pleural Mesothelioma Diagnosis and Staging.
V. Gerbaudo (2011)
10.1002/MRM.1910190206
Intravoxel incoherent motion imaging using spin echoes
D. Le Bihan (1991)
10.2214/AJR.06.1403
Diffusion-weighted MRI in the body: applications and challenges in oncology.
D. Koh (2007)
10.1148/RADIOL.2432060131
Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient.
M. Matoba (2007)
10.1093/OXFORDJOURNALS.AJE.A009093
Analysis of current trends in United States mesothelioma incidence.
B. Price (1997)
10.3174/ajnr.A1254
Preoperative Grading of Presumptive Low-Grade Astrocytomas on MR Imaging: Diagnostic Value of Minimum Apparent Diffusion Coefficient
E. J. Lee (2008)
10.1002/jmri.10139
In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging
B. Issa (2002)
10.2152/JMI.56.16
Is FDG-PET/CT useful for managing malignant pleural mesothelioma?
H. Otsuka (2009)
Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas.
M. Castillo (2001)
10.2463/MRMS.7.23
Apparent diffusion coefficients of breast tumors: clinical application.
M. Hatakenaka (2008)
10.1259/BJR/26525081
Diffusion-weighted MRI in the evaluation of renal lesions: preliminary results.
M. Cova (2004)
10.1007/978-3-540-78576-7_14
Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display.
T. Takahara (2004)
10.1097/RLI.0b013e3181817b3d
Computed Tomography, Positron Emission Tomography, Positron Emission Tomography/Computed Tomography, and Magnetic Resonance Imaging for Staging of Limited Pleural Mesothelioma: Initial Results
C. Plathow (2008)
10.1148/RADIOLOGY.161.2.3763909
MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders.
D. Le Bihan (1986)
10.1016/S0022-5223(99)70469-1
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
10.1007/s00330-008-0918-9
Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT
C. Plathow (2008)
10.1002/jmri.20149
Usefulness of the calculated apparent diffusion coefficient value in the differential diagnosis of retroperitoneal masses
T. Nakayama (2004)



This paper is referenced by
10.1016/j.jacr.2020.01.022
ACR Appropriateness Criteria® Occupational Lung Diseases.
C. Cox (2020)
10.1016/B978-0-12-802101-9.00009-0
Imaging Tools in Clinical Research
Ruth M. Dunne (2017)
10.2147/LCTT.S102113
Clinical staging of malignant pleural mesothelioma: current perspectives
M. Bonomi (2017)
10.1097/MCP.0000000000000265
Advances in pleural diseases: what is the future for medical thoracoscopy?
P. Lee (2016)
10.1097/00128594-199610000-00001
ACR Appropriateness Criteria®
Jamie Marko (2015)
Principles of diffusion MR imaging
(2012)
10.1016/j.jtho.2019.08.012
Radiologic Considerations And Standardization Of Malignant Pleural Mesothelioma (MPM) Imaging Within Clinical Trials: Consensus Statement From The NCI Thoracic Malignancy Steering Committee - International Association For The Study Of Lung Cancer - Mesothelioma Applied Research Foundation Clinical T
R. Gill (2019)
10.1016/j.lungcan.2013.08.005
Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group.
S. Armato (2013)
10.1016/j.cpet.2011.04.001
Multimodality Imaging Review of Malignant Pleural Mesothelioma Diagnosis and Staging.
V. Gerbaudo (2011)
10.1148/radiol.12110872
Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging--initial experience.
J. Coolen (2012)
10.21037/atm.2017.03.97
Overview of treatment related complications in malignant pleural mesothelioma.
D. Murphy (2017)
10.1016/j.soc.2014.06.005
Imaging of thoracic cavity tumors.
S. Hayes (2014)
10.1007/978-3-030-27233-3
The Thorax
Daniele Regge (2020)
10.1097/RTI.0000000000000190
Diffusion-weighted Magnetic Resonance Imaging in the Differential Diagnosis of Benign and Metastatic Malignant Pleural Thickening
N. Inan (2016)
10.1017/9781316402009.004
Multi-modality Imaging of Pleural and Peritoneal Disease
J. Cunningham (2018)
10.1097/MCP.0000000000000177
MRI of pleural diseases
J. Coolen (2015)
10.1007/978-3-030-27233-3_8
Primary Tumors of the Pleura
R. Ledda (2020)
10.1259/bjr.20160289
Role of respiratory-triggered diffusion-weighted MRI in the assessment of pleural disease.
M. Revelli (2016)
10.1177/0004563217741145
Biomarkers in mesothelioma
D. Arnold (2018)
10.1016/j.crad.2019.12.001
The role of imaging in malignant pleural mesothelioma: an update after the 2018 BTS guidelines.
S. Sinha (2020)
10.1200/JCO.2008.19.8523
Malignant pleural mesothelioma.
A. Tsao (2009)
Occupational Lung Diseases
J. Chung (2019)
10.1038/s41379-019-0320-y
Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas
S. Dacic (2019)
THE ROLE OF RADIOLOGY IN MPM
(2018)
10.1177/1753465811408637
Advances in the diagnosis of pleural disease in lung cancer
K. See (2011)
10.1007/s13244-015-0441-x
Imaging characteristics of pleural tumours
L. De Paoli (2015)
10.21037/shc.2018.07.01
Advances in mesothelioma imaging and implications for surgical management
K. Blyth (2018)
10.1016/j.mric.2015.01.006
Novel MR Imaging Applications for Pleural evaluation.
R. Gill (2015)
10.1016/j.lungcan.2015.07.011
Imaging in pleural mesothelioma: A review of the 12th International Conference of the International Mesothelioma Interest Group.
S. Armato (2015)
10.21037/jtd.2017.07.86
The value of delayed phase enhanced imaging in malignant pleural mesothelioma.
Akash M Patel (2017)
10.1016/j.jtho.2019.08.2506
EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach.
A. Nicholson (2019)
10.1055/s-0033-1363449
New applications of magnetic resonance imaging for thoracic oncology.
Y. Ohno (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar